MEDraysintell to showcase its expert reports at EANM

LOUVAIN-LA-NEUVE, Belgium - Oct. 6, 2015 - PRLog -- MEDraysintell will display its series of market reports and directories on Nuclear Medicine, Proton Therapy and Brachytherapy, during the EANM –European Association of Nuclear Medicine– congress (Hamburg, Germany, October 11-13, 2015). http://eanm15.eanm.org/

Visitors are welcome in the Rad4Med.be pavilion booth #177/183/184.

Nuclear Medicine World Market Report & Directory, Edition 2015: a 930 pages report & directory describing and analyzing over 335 radiopharmaceuticals and radionuclides and more than 160 companies and institutions active in nuclear medicine.

Cyclotrons used in Nuclear Medicine, World Market Report & Directory, Edition 2015: this first edition of the Cyclotrons report and directory will provide a complete review of the cyclotrons market worldwide, with a comprehensive profile of companies currently developing and/or supplying cyclotrons. Publication is expected later in the year.

Proton Therapy world market report, Edition 2015: the most comprehensive evaluation of the world proton therapy industry. This report includes a complete market review and contains a detailed profile of all promoters, manufacturers or developers of proton and carbon therapy equipment.

Opportunities in Brachytherapy, Edition 2014: a comprehensive review of available radioisotopes, products and equipment and a detailed profile of companies active in brachytherapy. This 320-page report covers LDR, HDR, electronic brachytherapy and microspheres, showing novel developments and providing details on market opportunities and companies active in this field.

We look forward to seeing you in Hamburg!

About MEDraysintell
Strategic intelligence for the radiation healthcare
Bringing value to Businesses and Investors!

MEDraysintell was founded in 2013 by Paul-Emmanuel Goethals (CSIntell) and Richard Zimmermann (Chrysalium Consulting). It combines over 40 years of experience in nuclear medicine, proton therapy and radiotherapy. We aim to form an international team of experts in the field of medical radiation to provide strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy to help our clients better understand the market – the competitive environment as well as the potential for mergers and acquisitions (M&A) – and technology development. MEDraysintell supports the decision process of manufacturers of radiopharmaceuticals and therapeutic radioisotopes, suppliers of equipment and software and members of the investor community.
www.medraysintell.com